Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  HIV Infection

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 77 articles:
HTML format

Single Articles

    November 2023
    Preventing healers from becoming killers.
    Lancet. 2023;402:1805.

  2. NUNEZ I, Valdes-Ferrer SI
    Classifying necrotising mpox as an AIDS-defining condition - Authors' reply.
    Lancet. 2023;402:1752.

  3. MITJA O, Paredes R, Cabtree B, Orkin C, et al
    Classifying necrotising mpox as an AIDS-defining condition.
    Lancet. 2023;402:1751-1752.

  4. WONG M, Damon IK, Zucker J, Foote MMK, et al
    ART initiation for people living with HIV with severe mpox.
    Lancet. 2023;402:1750.

  5. KASPER T, Yamey G, Dwyer S, McDade KK, et al
    Rethinking how development assistance for health can catalyse progress on primary health care.
    Lancet. 2023 Nov 10:S0140-6736(23)01813-5. doi: 10.1016/S0140-6736(23)01813.
    PubMed     Abstract available

    October 2023
  6. MEMISH ZA, Blumberg L, Al-Maani AS, Baru R, et al
    Moving cholera vaccines ahead of the epidemic curve.
    Lancet. 2023 Oct 17:S0140-6736(23)02244-4. doi: 10.1016/S0140-6736(23)02244.

  7. KIVUYO S, Birungi J, Okebe J, Wang D, et al
    Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial.
    Lancet. 2023;402:1241-1250.
    PubMed     Abstract available

  8. BALDEH M, Kizito S
    Call to action: HIV among adolescents in Sierra Leone.
    Lancet. 2023;402:1240.

  9. KISIGO GA, Peck RN
    Integrating HIV, hypertension, and diabetes primary care in Africa.
    Lancet. 2023;402:1211-1213.

    September 2023
  10. KAVANAGH MM, Wenham C, Massard da Fonseca E, Helfer LR, et al
    Increasing compliance with international pandemic law: international relations and new global health agreements.
    Lancet. 2023 Sep 4:S0140-6736(23)01527-1. doi: 10.1016/S0140-6736(23)01527.
    PubMed     Abstract available

    August 2023
  11. ZHU DT, Friedman J, Bourgois P, Montero F, et al
    The emerging fentanyl-xylazine syndemic in the USA: challenges and future directions.
    Lancet. 2023 Aug 24:S0140-6736(23)01686-0. doi: 10.1016/S0140-6736(23)01686.

    Ending the HIV pandemic: preparing for the future.
    Lancet. 2023;402:585.

  13. MARTIN CA, Medisauskaite A, Gogoi M, Teece L, et al
    Discrimination, feeling undervalued, and health-care workforce attrition: an analysis from the UK-REACH study.
    Lancet. 2023 Aug 18:S0140-6736(23)01365-X. doi: 10.1016/S0140-6736(23)01365.

  14. Cause-specific mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.
    Lancet. 2023 Aug 3:S0140-6736(23)01088-7. doi: 10.1016/S0140-6736(23)01088.
    PubMed     Abstract available

    July 2023
  15. BROYLES LN, Luo R, Boeras D, Vojnov L, et al
    The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review.
    Lancet. 2023 Jul 21:S0140-6736(23)00877-2. doi: 10.1016/S0140-6736(23)00877.
    PubMed     Abstract available

  16. BEKKER LG, Smith P, Ntusi NAB
    HIV is sexually untransmittable when viral load is undetectable.
    Lancet. 2023 Jul 21:S0140-6736(23)01519-2. doi: 10.1016/S0140-6736(23)01519.

    Ethnic conflict hampering health services in Manipur, India.
    Lancet. 2023;402:94.

    June 2023

  18. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
    PubMed     Abstract available

    May 2023
  19. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
    No time for complacency on COVID-19 in Europe.
    Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.

  20. ZEGGAGH J, Ferraris O, Salmona M, Tarantola A, et al
    Second clinical episode of hMPX virus in a man having sex with men.
    Lancet. 2023;401:1610.

    April 2023
  21. O'SHEA J, Daskalakis D, Brooks JT
    The emergence of mpox as an HIV-related opportunistic infection.
    Lancet. 2023;401:1264.

    PEPFAR at 20.
    Lancet. 2023;401:1145-1146.

  23. NKENGASONG J, Ratevosian J
    Legal and policy barriers for an effective HIV/AIDS response.
    Lancet. 2023 Apr 5:S0140-6736(23)00729-8. doi: 10.1016/S0140-6736(23)00729.

    March 2023
  24. NUNEZ I, Valdes-Ferrer SI
    Fulminant mpox as an AIDS-defining condition: useful or stigmatising?
    Lancet. 2023;401:881-884.

  25. WATTS G
    Bern-Thomas Nyang'wa: getting things done in TB and HIV.
    Lancet. 2023 Mar 17:S0140-6736(23)00576-7. doi: 10.1016/S0140-6736(23)00576.

  26. MADANITSA M, Barsosio HC, Minja DTR, Mtove G, et al
    Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlle
    Lancet. 2023 Mar 10:S0140-6736(22)02535-1. doi: 10.1016/S0140-6736(22)02535.
    PubMed     Abstract available

    February 2023
  27. MITJA O, Alemany A, Marks M, Lezama Mora JI, et al
    Mpox in people with advanced HIV infection: a global case series.
    Lancet. 2023 Feb 20:S0140-6736(23)00273-8. doi: 10.1016/S0140-6736(23)00273.
    PubMed     Abstract available

    January 2023
  28. KIRBY T, Thornber-Dunwell M
    10 years on-high-risk practices on the London gay scene.
    Lancet. 2023;401:94-95.

    December 2022
  29. BYANYIMA W, Lauterbach K, Kavanagh MM
    Community pandemic response: the importance of action led by communities and the public sector.
    Lancet. 2022 Dec 14:S0140-6736(22)02575-2. doi: 10.1016/S0140-6736(22)02575.

    Pakistan's growing HIV epidemic.
    Lancet. 2022;400:2031.

    November 2022
  31. THORNHILL JP, Palich R, Ghosn J, Walmsley S, et al
    Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series.
    Lancet. 2022 Nov 17:S0140-6736(22)02187-0. doi: 10.1016/S0140-6736(22)02187.
    PubMed     Abstract available

  32. GOODALL RL, Meredith SK, Nunn AJ, Bayissa A, et al
    Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
    Lancet. 2022 Nov 7. pii: S0140-6736(22)02078.
    PubMed     Abstract available

  33. JACKSON S, Kabir Z, Comiskey C
    Divergence in pace of decline in tuberculosis rates among migrants versus non-migrants in Ireland from 2011 to 2020.
    Lancet. 2022;400 Suppl 1:S52.
    PubMed     Abstract available

    October 2022
  34. MYERS B, Lombard CJ, Lund C, Joska JA, et al
    Comparing dedicated and designated approaches to integrating task-shared psychological interventions into chronic disease care in South Africa: a three-arm, cluster randomised, multicentre, open-label trial.
    Lancet. 2022;400:1321-1333.
    PubMed     Abstract available

  35. PAN D, Sze S, Nazareth J, Martin CA, et al
    The monkeypox case definition in the UK is broad - Authors' reply.
    Lancet. 2022;400:1301-1302.

  36. KIRBY T
    Anthony Fauci: moving on.
    Lancet. 2022;400:1182-1183.

    September 2022
  37. LUO R, Fong Y, Boeras D, Jani I, et al
    The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
    Lancet. 2022;400:887-895.
    PubMed     Abstract available

  38. TECHNAU KG, Mazanderani AH
    Point-of-care HIV diagnosis for infants: the outcomes we need to achieve.
    Lancet. 2022;400:864-865.

    August 2022
    Botswana's HIV/AIDS success.
    Lancet. 2022;400:480-481.

  40. TARIN-VICENTE EJ, Alemany A, Agud-Dios M, Ubals M, et al
    Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study.
    Lancet. 2022 Aug 8. pii: S0140-6736(22)01436.
    PubMed     Abstract available

    July 2022
  41. MAYER KH, Phanuphak N, Mgodi N, Grinsztejn B, et al
    New HIV prevention approaches: promise, praxis, and pitfalls.
    Lancet. 2022;400:257-259.

  42. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
    Lancet. 2022;400:185-235.
    PubMed     Abstract available

  43. BOOTH A
    New HIV law welcomed in Argentina.
    Lancet. 2022;400:149.

  44. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.

    June 2022
  45. CHARANI E, McKee M, Balasegaram M, Mendelson M, et al
    Global burden of antimicrobial resistance: essential pieces of a global puzzle.
    Lancet. 2022;399:2346-2347.

  46. PAN D, Sze S, Nazareth J, Martin CA, et al
    Monkeypox in the UK: arguments for a broader case definition.
    Lancet. 2022 Jun 15. pii: S0140-6736(22)01101.

    May 2022
  47. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.

  48. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 May 23. pii: S0140-6736(22)00532.
    PubMed     Abstract available

  49. WATTS G
    Luc Antoine Montagnier.
    Lancet. 2022;399:1862.

    April 2022
  50. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.

  51. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.

  52. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.

  53. MUDZINGWA EK, Parker IK
    Long-acting injections for HIV prevention among women in sub-Saharan Africa.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00613.

  54. DELANY-MORETLWE S, Hughes JP, Bock P, Ouma SG, et al
    Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00538.
    PubMed     Abstract available

    March 2022
  55. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.

  56. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.

  57. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    PubMed     Abstract available

  58. Progress in health among regions of Ethiopia, 1990-2019: a subnational country analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02868.
    PubMed     Abstract available

  59. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.

    February 2022
  60. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.

  61. MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
    Decoupling of omicron variant infections and severe COVID-19.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.

  62. MINALGA B, Chung C, Davids JD, Martin A, et al
    Research on transgender people must benefit transgender people.
    Lancet. 2022;399:628.

  63. SIVA N
    Gilead and ViiV Healthcare reach settlement over HIV drug.
    Lancet. 2022;399:618.

  64. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.

  65. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.

  66. VAN DER MERWE LL, Cloete A, Skinner D
    How HIV advocacy can be used to ensure quality transgender health care: lessons from South Africa.
    Lancet. 2022 Feb 4. pii: S0140-6736(22)00177.

    January 2022
  67. WOLTER N, Jassat W, Walaza S, Welch R, et al
    Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
    PubMed     Abstract available

  68. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.

    December 2021
  69. HOSSEINPOOR AR, Bergen N, Kirkby K, Schlotheuber A, et al
    Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria.
    Lancet. 2021 Dec 8. pii: S0140-6736(21)02756.

  70. MENDELSON M, Venter F, Moshabela M, Gray G, et al
    The political theatre of the UK's travel ban on South Africa.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.

    November 2021
  71. SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
    Global HIV efforts need to focus on key populations in LMICs.
    Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.

  72. JOLLY J
    A reproductive justice response to HIV/AIDS and COVID-19.
    Lancet. 2021;398:1958-1959.

  73. LANE R
    Pascale Ondoa: strengthening laboratory medicine in Africa.
    Lancet. 2021;398:1955.

  74. FALCARO M, Castanon A, Ndlela B, Checchi M, et al
    The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02178.
    PubMed     Abstract available

    October 2021

  75. Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2021;398:1593-1618.
    PubMed     Abstract available

    Nkengasong tipped to lead PEPFAR.
    Lancet. 2021;398:e15.

    July 2021
    Etheldreda Nakimuli-Mpungu: innovator in mental health.
    Lancet. 2021;398:109.

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.